Nasdaq:US$13.30 (+0.08) | HKEX:HK$20.50 (-0.70) | AIM:£2.10 (-0.09)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma